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ABSTRACT
Bhana, Saheel. MS. The University of Memphis. August 2013. Synthesis and
Characterization of iron oxide-gold core-shell nanoparticles in different shapes. Major
Professor: Xiaohua Huang. Ph.D.
Hybrid nanomaterials possessing dual magnetic/optical properties are of
considerable interest to many areas, ranging from material science to medicine and
biology. They are promising for a broad range of applications including catalysis, energy
conversion, biological separation, medical diagnosis and treatment. Anisotropic
magnetic-optical nanoparticles give better or new properties compared to spherical ones
due to their high curvature and polarization-sensitive geometry. However, the
engineering of compact and uniform anisotropic magnetic-optical core-shell
nanoparticles remains a major challenge. The work of this thesis is aimed at the
preparation and characterization of magnetic-optical core-shell hybrid NPs in different
shapes and sizes. Iron oxide-gold core-shell nanoparticles in spherical, oval and pin
shapes were prepared. Our studies have shown that iron oxide-gold core-shell
nanoparticles, despite the shapes, exhibit 10 times better absorption properties compared
to solid gold nanoparticles. The availability of these nanoparticles would make an
important impact in biomedicine, material science and other fields.
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PREFACE
The majority of the work from this thesis is written based on a journal article
entitled, “Synthesis and properties of near infrared-absorbing magnetic–optical
nanopins” This article is published in the journal Nanoscale.
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CHAPTER 1. INTRODUCTION
1.1. Background
The word nano, derived from the Greek nanos, meaning "dwarf", is used to
describe any material or property having dimensions on the nanometer scale (1-100 nm).
Nanoparticles (NPs) are all around us in nature and have been around forever, but only
over the last few decades have the experimental methods become available which allow
chemists to synthesize nanomaterials in a controlled and reproducible way.1 These
nanomaterials, behave significantly differently than bulk materials due to their unique
surface and quantum confinement effects.2 These NPs display different physical and
chemical properties which have made them a major focus of research over the past
decade. One major application of the use of NPs is in biomedicine. A few of the major
classes of NPs used for biomedical applications are magnetic and gold NPs.
1.2. Magnetic nanoparticles
Magnetic nanoparticles (NPs) are being used in an increasing number of medical
applications. Some important properties of magnetic NPs that contribute to their medical
applications include nontoxicity, biocompatibility, and high-level accumulation in the
target tissue. Iron oxide (IO), Magnetite, (Fe3O4) and Maghemite (Fe2O3), are the most
widely used materials due to their biocompatibility and ease of synthesis in a suitable size
range for biomedical applications.3 Magnetite is of particular interest due to its proven
biocompatibility. Superparamagnetic nanoparticles do not exhibit a magnetic response in
the absence of an external magnetic field. For magnetic-related biomedical applications,
the nanoparticles should be superparamagnetic to avoid magnetization residue-induced
aggregation.3 It is well known that the magnetic property of iron oxide nanoparticles is
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size dependent. Fe3O4 nanoparticles are typically superparamagnetic at ≤ 30 nm, with
larger sizes displaying ferromagnetic properties. Also magnetic nanoparticles less than 4
nm in size are typically not responsive enough to an external magnetic field for
magnetophoretic motion in real time.4 It is also advantageous for the nanoparticles to
have similar dimensions to that of proteins (5-50 nm), viruses (20-500 nm), genes (2-100
nm), and other biological molecules for use in bio-applications.4
IO NPs have been synthesized by a variety of methods including co-precipitation,
thermal decomposition, microemulsion, and hydrothermal synthesis. In many methods it
is difficult to control the size. The co-precipitation method usually leads to polydispersed
particles. High quality IO NPs have been successfully made using high temperature
thermal decomposition methods.5
IO NPs have been widely used for cell magnetic separation, T2-weighted
magnetic resonance imaging (MRI), drug delivery, and hyperthermia treatment due to
their unique responses to magnetic force.4 Magnetic separation using IO NPs has been
widely used in most areas of biosciences and biotechnology for separations of chemical
and bimolecular molecules, biological cells and pathogens. IO NPs have been used for
separation of rare cancer cells in the blood.6 In fact, the CellSearch system, the only
technique approved by U.S. Food and Drug Administration (FDA) for clinical utilization,
uses magnetic beads with the anti-epithelial cell adhesion molecules (anti-EpCAM)
antibodies to separate and enrich circulating tumor cells (CTCs) with the use of external
permanent magnets.7 Cell labeling with IO NPs has also been commonly used for MRI.
The most common labeling technique is directly attaching IO NPs to the cell surface by
specific binding of the NPs to the cells. Attaching a ligand that is specific to the target
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cell allows for efficient cell uptake via receptor-mediated endocytosis. A variety of
potential ligands have been successfully used to facilitate receptor-mediated endocytosis
of conjugated NPs, including monoclonal antibodies (Mabs). Antibody-antigen binding
provides a highly accurate method for cell labeling. Cell targeting can be achieved with
targeting ligands such as growth factors, insulin, albumin, lactoferrin and transferrin
because the receptors for these ligands are usually overexpressed on the surface of
malignant cells. Most of these ligands are stable and thus ideal for bioconjugation to
targeted cells. IO NPs can also be used in immunoassays, which are commonly used for
medical examinations in detection of viruses or an assay of various hormones. The
magnetic separation can greatly reduce the duration of separation steps and therefore save
time.
MRI is currently one of the most important imaging modalities in clinical settings.
MRI offers high spatial resolution. MRI is based on nuclear magnetic resonance (NMR)
signal of protons under a strong static magnetic field. MRI relies on the minute amount
of magnetic moment on a proton and the very large number of protons present in
biological tissue, which allows a measurable amount in the presence of a strong magnetic
field.4 A radio frequency transverse field is applied in a pulsed manner. This causes the
nuclei to produce a rotating magnetic field detectable by the scanner and this information
is recorded to construct an image of the scanned area of the body. Superparamagnetic
NPs are known to be effective contrast agents in clinical settings. These NPs reduce the
signal of T2-weighted images which lowers negative contrast.8 IO NPs have also shown
the ability to detect apoptosis and self-destruction of cells by MRI.9 IO NPs conjugated
for tumor targeting can also be utilized as an effective agent for MRI of cancer
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metastasis.10 Suziki et al. specifically conjugated Fe3O4 NPs to monoclonal antibodies
(MAbs) for active targeting to cancer cells. They first conjugated poly-ethylene glycol
(PEG)-coated Fe3O4 NPs to a MAb that was specific to a human glioma cell surface
antigen. They then injected the particles intravenously into nude mice with tumors. The
IO NPs accumulated into the tumor tissue after 24 hours. A 50% decrease in the T2
signal intensity of the tumor was observed.11 This demonstrated that IO NPs could be
used as great contrast agents for enhancing MR imaging.
Hyperthermia, the elevation of localized tissue temperature, is a promising
approach to cancer therapy. Hyperthermia treatment is a usually used in supplement with
chemotherapy, radiotherapy, and surgery in cancer therapy. In hyperthermia treatment,
the temperature of the tissue is heated to 43 - 44oC. But, higher temperatures will have a
greater "kill rate" of tumor cells. The major challenge of hyperthermia treatment is the
difficulty of heating the localized tumor cells without damaging the surrounding tissue.
IO NPs have been one of the major contrast agents for inducing hyperthermia.12 In the
presence of an alternating magnetic field (AMF), the NPs are heated. The rotation in the
magnetic vector of the particle, Neel Relaxation, is the dominant mechanism of heating.12
Therefore in an AMF when the dipoles are rapidly rotating back and forth congruently
with the magnetic field, it creates a "magnetic friction" which generates heat. The size
and the shape of the IO NPs play an important role in the heating. Jordan and co-workers
successfully demonstrated the use of superparamagnetic IO NPs in hyperthermia of brain
tumors.13 They directly injected the particles into tumors of human patients. The particles
were then heated by an external AMF. The maximum temperature reached within the
tumor was between 42.4 and 49.5 oC. There were no significant toxicities observed
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during their study.14 Clinical studies performed so far have shown that interstitial brain
hyperthermia is feasible with the use of IO NPs and the toxicity is acceptable if the
heating and target volume is carefully monitored.
Drug delivery is also a promising application of magnetic NPs. The NPs can be
used as drug carriers for site-specific delivery. The surface chemistry, size, and charge of
the NPs are very important for delivery into the blood and biocompatibility of the
particles.3 Internalization is strongly dependent on the size and magnetic properties of
the particles. Larger particles greater than 200 nm are typically separated by the spleen
and removed by the cells of the reticuloendothelial system, RES.15 Particles less than 10
nm are rapidly removed by renal clearance. Therefore, NPs with sizes from 10 to 100 nm
show the most prolonged blood circulation times. When the NPs aggregate they tend to
adsorb plasma proteins which are in turn taken up by the RES due to their hydrophobic
surface. Therefore it is advantageous to coat the particles with an amphiphilic polymer
such as PEG. PEG significantly increases the blood circulation time by minimizing
protein adsorption to the NPs.16 It has been shown that PEG modified IO NPs showed a
higher cell uptake in breast cancer (BT20) cells due to PEG high solubility in cell
membranes.17 Once the drug loaded NPs are injected, they can be guided under a
localized magnetic field and used for therapy. IO NPs were used for the first time in
animal studies by Lubbe et al.18 They were also tested in cancer patients.18 In the studies
on cancer patients, epirubicine was attached to the particles via electrostatic interactions.
Epirubicine was effectively targeted to the tumor site in 6 patients. The particles inside
the liver appeared to produce no toxic effects.18 Fe3O4 particles have been used to deliver
cytotoxic drugs to osteosarcoma sites directed by permanent magnets. The NPs showed a
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four-fold increase in drug delivery to the tumor site and a significant increase in antitumor activity with the elimination of weight loss as a side effect compared to direct drug
injection (non-magnetic) delivery.19
Although there are many advantages to magnetic NPs at present, there are still
limitations. Despite the great resolution of MRI, it is not as sensitive as optical imaging.
Magnetic NPs do possess the ability to generate heat which can be used for hyperthermia
treatment, but they typically can only reach temperatures near 40oC unless a very high
power source is used. Magnetic NPs also have limited capabilities in spectroscopic
detection due to their inability to absorb light.
1.3. Metallic Nanoparticles
Metallic (plasmonic) NPs are made of noble metals and exhibit special surface
plasmon resonance (SPR), a photophysical phenomenon leading to strongly enhanced
radiative (e.g. absorption and scattering) and nonradiative photothermal properties. For
biomedical purposes, Au NPs are popular metallic NPs. There have been an extensive
amount of studies done on the toxicity of Au NPs and the general conclusion from these
studies is that Au NPs are biologically inert, and non-toxic.20-25 Au NPs have been used
in biomedical applications since their first colloidal syntheses more than three centuries
ago. Unlike bulk or molecular-scale gold, nanoscale gold exhibits vivid colors which
have made them widely popular objects of study for chemists, physicists, and now
biomedical practitioners (Figure 1.1).
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Figure 1.1. Gold nanoparticles commonly used in biomedical applications.20

What makes these metallic NPs unique is their interaction with incident light. In
the presence of the oscillating electromagnetic field of light, the conduction band
electrons of a metal nanoparticle undergo a collective coherent oscillation in resonance
with the frequency of incident light leading to constructive interferences, which is called
the SPR effect.20 As a result of the SPR oscillation, all radiative properties, such as light
absorption, fluorescence, Rayleigh (Mie) scattering, and Raman scattering are enhanced
by orders of magnitude.26 Different geometries of Au NPs display different optical
properties. The SPR effect is dependent on the particle size, shape, structure, the
dielectric properties of the metal, and the surrounding medium, as all of these factors
affect the electron charge density on the particle surface.20
Currently most colloidal methods for synthesizing Au NPs use a gold salt which
is reduced in the presence of surface capping ligands that prevent aggregation and
stabilize the particles by electrostatic and/or physical repulsion. Particle size is easily
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tunable by varying the gold ion/reducing agent or gold ion/surfactant ratio, with larger
(and typically less monodisperse) sizes obtained from larger ratios.20
The intriguing properties of Au NPs have led to a wide variety of biomedical
applications including optical bio-imaging, spectroscopic detection, bio-sensing, and
photothermal therapy.27-32

The strong scattering from these Au NPs greatly increases

their functionality in optical imaging. Furthermore, the optical imaging resolving power
using these NPs has greatly increased. Dark-field microscopy remains one of the most
popular bio-imaging methods using Au NPs.26 In dark-field microscopy, the light
entering the objective lens is only the light scattered by the object at side lighting (similar
to the Tyndall effect); therefore, the scattering object looks bright against a dark
background. Compared with fluorescent labels, Au NPs have a much greater potential to
reveal bio-specific interactions with the use of dark-field microscopy, because the particle
scattering cross section is three to five orders of magnitude greater than the fluorescence
cross section for a single molecule.33 This principle was demonstrated for the first time
by Mostafa El-Sayed’s group, which conjugated Au NPs with a tumor-antigen specific
antibodies to the cancer cell surface.34 They then used dark-field microscopy to image
cancer cells after incubated with antibody-conjugated Au NPs (Figure 1.2).34 With darkfield microscopy it becomes possible to ‘‘map out’’ a tumor with an accuracy of several
cells. This is a simple and rapid method for cancer diagnosis based on Au NPs.

8

a

b

Figure 1.2. Dark-field microscopy of HaCat healthy cells (a) and HSC-3 cancerous (b)
cells by using Au NPs conjugated with anti-epidermal growth factor antibodies. The
images are cited from reference.34

Other successful methods of bio-imaging using Au NPs include optical coherence
tomography,35 X-ray and magnetic resonance tomography,36 photoacoustic microscopy
and tomography,37 fluorescence correlation microscopy,38 among other techniques. These
methods also successfully use various sized and shaped gold nanoparticles. The strong
light scattering properties of gold nanoparticles allow them to be a very useful qualitative
tool in bio-imaging.
Due to the strong surface electromagnetic fields that propagate around metallic
NPs, molecules in close proximity to the surface of these NPs can also exhibit different
properties. An example of this plasmonic near-field effect is the large enhancement of
the Raman scattering by species adsorbed onto the surface of the NPs known as surfaceenhanced Raman scattering (SERS).39 SERS is known to be an ultrasensitive, down to
single particle and single molecule level.40 It results in sharp fingerprint-like signals
which are distinct from other interferences within the complex biological milieu.39 Au
NPs are desirable substrates for SERS-based biomedical detection because of their facile
synthesis and excellent biocompatibility. Raman reporters (organic dye molecules highly9

delocalized pi electrons) are adsorbed or covalently conjugated to the NPs. This results
in a strong SERS signal that is specific to the attached Raman reporter. This is a highly
specific method because it avoids signal interferences from competing species due to the
finger-print features of SERS signals. The enhancement of the Raman signal can be as
high as 1014 therefore proving to be very advantageous in ultra-sensitive assays.40 Raman
reporters have been used to detect biomarkers in cancer, viral and bacterial
microorganisms and other diseases.41-43 Raman reporters have recently been used as a
tool for the detection of CTCs.44 Wang et al. reported that epidermal growth factor
(EGF)-conjugated, SERS-tagged Au NPs can detect CTCs in mice and human blood
samples.44 Their Raman reporters showed high specificity to head and neck cancer cells
in a sea of white blood cells with a sensitivity threshold of 5–50 cells per mL blood.44
Compared to fluorescence detection, this SERS approach is advantageous because the
signals are much sharper and distinct from complex biological fluids therefore
minimizing effects from biological background fluorescence.45
Photothermal therapy is currently one of the most promising research applications
in the treatment of cancer and other diseases.26 When metallic NPs are exposed to laser
light in resonance with their surface plasmon oscillation, they have the ability to strongly
absorb the light and rapidly convert it into heat via a series of photophysical processes.20
Current gold-based NPs for photothermal cancer therapy are nanospheres, nanorods,
nanoshells, and nanocages.46 Gold nanospheres do not absorb light in the near-infrared
(NIR) window (650-900 nm), whereas nanorods, nanoshells, and nanocages have strong
NIR absorption.47 Light penetration is optimal in the NIR window due to minimal
absorption by water and hemoglobin in the tissue.39 Thus, the gold nanorods, nanoshells,
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and nanocages are very promising for photothermal cancer therapy. Au NPs have the
advantage of higher absorption due to their high molar absorptivity (108-9 M-1 cm-1) ,48
higher solubility, efficient absorption in NIR window, and facile conjugation with
targeting molecules and drugs. These properties make Au NPs the most promising
candidates for photothermal therapy of cancer and various pathogenic diseases.20
Currently, there are many publications describing Au NPs for photothermal ablation of
cancer cells and various other diseases.20,39 El-Sayed et al. first demonstrated the use of
gold nanorods for in vivo photothermal therapy in 2008, showing that the method was
able to significantly inhibit tumor growth following a single 10 minute laser exposure
experiment.49 Gold nanorods have also been shown to ablate tumors in mouse models of
colon cancer and squamous cell carcinoma.49 Xia et al. used targeted nanocages
approximately 45 nm in length and with plasmonic absorption maxima at 810 nm, to
ablate SK-BR-3 breast cancer cells in cell culture studies.50 With the use of PEG-coated
gold nanorods injected at tumor sites of mice, Bhatia et al. were able to use X-ray
computed tomography as a guide for photothermal therapy with high efficacy due to the
optical properties of gold nanoparticles.51
Drug Delivery is another promising application of Au NPs. Drug loading onto Au
NPs can be done with high efficiency due to the high surface area of the particles. Drugloaded Au NPs show enhanced pharmacokinetics and tissue accumulation compared to
free drugs.52 Due to the leaky vasculature of tumor cells, the enhanced permeability and
retention (EPR) effect leads to the preferential accumulation of the NPs at the tumor
sites.53 Au NPs are a useful tool for the delivery of the drugs to cellular destinations due
to their ease of synthesis, functionalization and biocompatibility. Another advantage of
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using Au NPs for drug delivery is their capability for bioimaging due to their strong
optical properties. Recently, paclitaxel, (PTX), an anticancer drug, was loaded onto gold
nanorods with a high density (2 x 104 PTX/Au NR) via a facile, fast, and highly efficient
method. The drug was efficiently released to exert cytotoxic effects via hydrophobic
interactions of the drug and apolar lipid membrane.28 Multimodal delivery systems can
also be used, where Au NPs are loaded with several drugs (hydrophilic and hydrophobic)
as well as target molecules to ensure better delivery to the target cell and also help anchor
the drugs.20 Au NPs are also excellent delivery vectors for substances such as antibiotics
and other antibacterial agents. Gu et al. have prepared a stable vancomycin–colloidal
gold complex and showed its effectiveness toward various (including vancomycinresistant) enteropathogenic strains of Escherichia coli, Enterococcus faecium, and
Enterococcus faecalis.54
Au NPs offer many applications in biomedicine due to their unique chemical
properties such as excellent ability to absorb and scatter light, ability to transfer light
energy as heat, facile surface modification, and biocompatibility. Although Au NPs have
these unique properties described above, they still have limitations. Au NPs cannot be
used for magnetic separation due to the their lack of magnetic properties. Likewise, they
lack capabilities for MR imaging. Thus, it will be desirable to develop hybrid NPs that
possess both magnetic and optical properties.
1.4. Iron oxide-gold core-shell nanoparticles
Although magnetic and plasmonic nanoparticles are two of the most widely used
nanoplatforms in biomedicine, each type of nanoparticle displays distinct limitations.
Combining these two platforms into a single hybrid nanoconstruct would create a highly
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attractive multi-modal system for biomedical applications. Due to the biocompatibility
and the excellent properties of IO and Au NPs, iron oxide core-gold shell (IO-Au) NPs
have attracted considerable interests. They are promising for a broad range of single and
multi-modal applications including MRI, optical imaging, cell separation, biosensing and
photothermal therapy.
Recently Zhou et al. used IO-Au NPs to isolate and detect proteins.55 They
coated the NPs with Raman reporters and conjugated them with antibodies specific to
protein specific antigen (PSA), one of the most widely used Food and Drug
Administration-approved biomarkers for cancer detection. They were able to isolate the
PSA by magnetic separation and detect rapidly with SERS. This was a simple, rapid
determination which did not require any sample pretreatment.55
The synthesis of these hybrid IO-Au NPs has gained great attention. A variety of
methods has been reported.56 However, most synthesis methods make IO-Au
nanospheres. For examples, Li et al. synthesized IO-Au NPs by linking two separately
prepared Fe3O4 and Au NPs through chemical bonds. The Fe3O4 were conjugated with a
thiol group. Then Au NPs were prepared separately by the reduction of a gold salt with
sodium borohydride. The two types of NPs were mixed together to form IO core with
gold seed spheres (Figure 1.3).57 This method does not make a uniform Au shell which
limits its plasmonic effects and its facile surface modification and does not have NIR
absorption which could limit its therapeutic effects.
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Figure 1.3. TEM image of IO-Au seeded nanospheres synthesized via chemical bonds by
Li et al.57

Sun and co-workers successfully prepared core/shell Fe3O4/Au NPs based on the
heterogeneous nucleation and growth of Au onto seeded NPs.58 They first reduced a gold
salt (HAuCl4) solution on the surface of Fe3O4 NPs with a solution of olelyamine. They
are then mixed with a stabilizing surfactant, cetyltrimethylammonium bromide (CTAB)
and sodium citrate. This method produces a smooth gold shell by simply adding more
gold salt in a reducing condition.58 By increasing the thickness of the gold shell they
showed a slight red shift in their maximum absorption from ~540-560 nm (Figure 1.4).
One limitation to this method for biomedical purposes is they use a small iron oxide core
(10 nm) which has limited magnetic properties. In addition, the nanospheres do not
exhibit NIR absorption even with thicker gold shells.
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Figure 1.4. (A) Absorption spectra of IO-Au/Ag shell nanospheres synthesized via a
nucleated growth of Au/Ag onto seeded nanoparticles by Sun et al (B) TEM image of IOAu nanospheres.58

Lyon et al. prepared IO-Au core-shell NPs by sequential deposition of Au onto
Fe3O4 NPs via an iterative hydroxylamine seeding method.59 The NPs absorb light
around 525 - 570 nm depending on the shell thickness. The particles generated by this
method are also limited due to weak magnetic properties and no absorption in the NIR
region. The synthesis method is also tedious due to the multiple depositions of gold
required to make a uniform shell.
NIR absorption is critical for in vivo imaging and therapy because of minimal
light absorption by water and hemoglobin in this range and the resulting optimal light
penetration in tissue.60 A few studies have demonstrated that NIR-absorbing magnetic–
optical NPs can be achieved by using large IO core and/or thick shell of Au, resulting in
NPs with overall size of around or greater than 100 nm. For examples, Wang et al.
developed a method in which magnetite NPs (~258 nm) were coated with a thin polymer
15

layer and then citrate stabilized gold nanoseeds were attached via electrostatic
interactions (Figure 1.5).61 A uniform gold shell was then developed by reducing
HAuCl4 onto the seeded NPs. Unlike the previous methods discussed above in which
direct coating of magnetic NPs with gold shells did not produce NIR absorption, NIR
absorption was achieved in this method with an total size of ~273 nm for the iron oxidegold core-shell NPs.

Figure 1.5. (a)Absorption spectra of iron oxide cores with various gold shell thickness (b)
TEM image of IO-Au nanoparticle.61

The authors speculated that the polymer gap, although very thin, helped maintain
the NIR absorption of the gold nanoshell, possibly by interrupting the interactions
between the gold shell and the magnetite core. However, the large size of core also
contributes to the NIR absorption of the hybrid NPs as shown previously on silica-gold
core-shell NPs.62 One potential limitation to the previous method is the large particle size
(273 nm). It is well know that for better tissue penetration and blood circulation,
nanoparticles with a smaller size are desirable (< 100nm).
16

Later, Wei et al. developed a method in which IO-Au core shell nanostars were
synthesized.63 They firstly synthesized IO NPs (~8-13 nm). The IO NPs were then
treated with AuCl32- at room temperature followed by heating to 190 °C in octyl ether for
90 min to form IO-Au core-shell NPs (~9-16 nm). The NPs were then deposited into a
micellar solution containing cetyltrimethylammonium bromide (CTAB), chloroauric acid
(HAuCl4), silver nitrate (AgNO3) under reduced conditions to grow into nanostars (~150200 nm). These particles exhibited absorption maxima around 800 nm, but their
magnetic properties are very limited because of the small size of the IO core (8-13 nm)
compared to the large overall size of the hybrid NPs. Jin et al. formulated NIR responsive
IO–Au nanospheres (50 nm or less) with ultrathin Au shells by building a polymer gap
between the IO core and the Au shell.64 The authors coated magnetite NPs (~25 nm)
with a polymer layer (~3 nm) with a charged peptide, poly- L -histidine. The peptide
allowed Au3+ ions to chelate onto the surface of the IO NPs which was then reduced to
Au0. The NPs with a very thin Au layer (1-3 nm) exhibit a broad NIR absorption. As the
shell thickness grows (4-5 nm), the core-shell NPs blue shifted to visible spectral region.
This method is limited for biomedical applications due to the expensive chemcials of the
synthesis (especially poly- L –histidine), making it a difficult method for large scale
synthesis.
1.5. Motivation
The development of nanomaterials that combine diagnostic and therapeutic
functions within a single nanoplatform is extremely important for molecular medicine.
IO and Au NPs are two of the most widely used nanoplatforms in biomedicine.
Combining these two platforms into a single hybrid nanoconstruct would create a highly
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attractive multi-modal system for biomedical applications. While the inner IO core could
serve as potential agents for MRI and separation, the outer Au shell would be a useful
tool for optical imaging, drug delivery, photothermal therapy, spectroscopic detection and
molecular targeting. However, it is challenging to develop IO-Au core-shell NPs with
optical properties in the NIR window while maintaining the superparamagnetic property
of the IO core. The importance of NIR absorption for photothermal therapy is essential
due to the minimal light absorption by water and hemoglobin and the resulting optimal
light penetration in tissue.60 Another key challenge is engineering IO-Au NPs for SERS
applications without dampening the magnetic properties.
Here, we have developed IO-Au core-shell NPs with varying morphology and
size with a single method. The method is advantageous due to the simplicity and the
feasibility of the synthesis of the core-shell NPs on a large scale. Our method also
provides an inexpensive way to synthesize IO-Au core-shell NPs. The hybrid NPs can
have an important impact on medical imaging, molecular diagnostics and cancer
therapeutics. The synthesis, morphology, magnetic and optical properties of these coreshell NPs are discussed in this thesis.
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CHAPTER 2. EXPERIMENTAL METHODS
2.1 Chemicals
All chemicals were purchased from Sigma-Aldrich and used as received unless
specified. QSY 21 carboxylic acid, succinimidyl ester (QSY 21) was purchased from
Life Technologies (Grand Island, NY, USA). Methoxy-PEG-thiol (mPEG-SH, MW
5000) was purchased from Laysan Bio, Inc (Arab, AL, USA). IO NPs (SHP 25) were
obtained from Ocean Nanotech (Springdale, AR, USA)
2.2 Synthesis of iron oxide-gold core-shell nanoparticles
IO-Au core-shell NPs were synthesized via a seed-mediated growth method with
modifications.65 Firstly, IO NPs (SHP 25) were coated with small silver (Ag) NPs to
form "seed" particles (Figure 2.1). This was done by reduction of Ag+-adsorbed IO NPs.
Specifically, 1 mL of 10 mM diamminesilver ion complex (Ag(NH3)2+) was prepared by
adding 20 uL of 1 M ammonia into 1 mL of 10 mM silver nitrate (AgNO3). After vortex
mixing for 2 to 5 min, 10 µL of the Ag(NH3)2+ complex was added to a reaction vessel
which contained 100 µL of 1 mg/mL negatively charged polymer-coated IO NPs and
stirred for 30 min. The Ag+-adsorbed IO NPs were purified by centrifugation (10,000
rpm, 8 min) and reconstituted with 0.25 mL of ultrapure water. Sodium borohydride
(NaBH4) (10 uL, 10 mm) was added to the reaction flask to reduce the Ag+ on the
surface of the IO NPs to form Ag-coated IO NPs. The solution was stirred for 40 minutes
to complete the reaction. The Ag-decorated IO NPs were purified by three rounds of
centrifugation and washing (10,000 rpm, 8 min), and were redispersed in 500 µL of
ultrapure water.
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Figure 2.1. Schematic illustration of Ag-decorated IO NPs.

The second step of the synthesis is the growth of Au shell on the Ag-decorated IO
NPs (Figure 2.2). In a typical procedure, 54 mg CTAB was added to 1.5 mL of ultrapure
water in a glass vial and then heated with stirring to dissolve. After allowing the solution
to cool to room temperature, 60 uL of 10 mM HAuCl4 was added to the reaction mixture
and the solution turned orange. The solution was allowed to stir for 10 minutes. To
make spherical IO-Au NPs, 23 µL of 40 mM L-ascorbic acid (AA) was quickly added to
reduce the HAuCl4 to HAuCl2. The reduction reaction changed the solution from orange
to colorless. The solution was then placed in a 25oC water bath and allowed to stir for 5
minutes. Next, a specified amount of Ag-decorated IO NP solution was rapidly injected
and the solution was stirred for 10 seconds. The mixture was then left still for the growth
of Au shell onto IO NPs. By varying the amount of the IO-Ag seed, the overall size of the
IO-Au NPs can be easily tuned. After a few minutes, the solution changed to a pinkcolor,
indicating the growth of iron oxide-gold nanospheres (IO-Au NSs). The growth process
was completed within 2 h.
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Figure 2.2. Schematic illustration of a typical procedure for the growth of Au shell onto
Ag-decorated IO NPs to form IO-Au core-shell NPs. The formation of spheres, ovals or
pins depending on the concentration of AgNO3 and AA.

For the preparation of IO-Au NPs nanoovals (IO-Au NOVs), 120 uL of 1 mM
AgNO3 was added after the addition of HAuCl4 solution. The solution was allowed to
stir for 10 minutes. Then, 23 µL of 40 mM AA was added to reduce the HAuCl4 to
HAuCl2 with the solution changing from orange-gold to colorless. The solution was then
placed in a 25oC water bath and allowed to stir for 5 minutes. Next, the Ag-decorated IO
NP solution was injected rapidly and the solution was allowed to stir for 10 seconds.
Then, the solution was left unstirred for an additional 2 h. After a few minutes, the
solution slowly began changing to purple, indicating the growth of IO-Au NOVs. By
varying the amount of the IO-Ag seed, the overall size of the IO-Au NPs can be facilely
tuned.
For the preparation of IO-Au nanopins (IO-Au NPINs), the same amount of
AgNO3 was added as the preparation of NOVs. Then, 150 µL of 40 mM AA was added
to reduce the HAuCl4 to HAuCl2 with the solution changing from orange-gold to
colorless very rapidly. The solution was placed in a 25oC water bath and allowed to stir
for 5 minutes. The Ag-decorated IO NP solution was injected rapidly and the solution
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was allowed to stir rapidly for 10 seconds. After the 10 second stirring, the growth
solution was left unstirred. By varying the amount of the IO-Ag seed, the overall size of
the IO-Au NPs can be facilely tuned. After a few minutes, the solution started to change
color to blue, indicating the growth of IO-Au NPs in pin shapes. All IO-Au NPs are
washed 3 times (10,000 rpm/10min) to remove excess CTAB in order for further
characterization.
2.3 Characterization of iron oxide-gold nanoparticles
The IO-Au NPs in different shapes were characterized by spectroscopic and
imaging methods in order to measure the optical absorption properties, size and shape,
and magnetic properties. The absorption spectra were measured using a VIS-NIR
absorption spectrometer (Ocean Optics, Dunedin, FL). To measure magnetic properties,
IO-Au NPs were made in bulk (200 mL scale). The particles were then purified and
condensed to 5 mL and placed on a watch glass. The solvent was then evaporated with
N2 gas and the NPs were placed in on oven to dry. After overnight drying the particles
were in powder form and the magnetic properties were measured using a vibration
sample magnetometer (Dexing Magnets, China). The magnetic properties of IO NPs were
also measured for a comparison. To further examine the magnetic properties of the NPs,
a solution of the NPs in water was placed against external magnets (12-tube magnet,
Qiagen). After a few hours, the magnetic NPs were separated from the solution and
attached to the vial wall against to the magnet. To examine the size and morphology of
the NPs, 10 uL of 0.1 nM NP solution was placed onto a 200 mesh copper grid with a
formvar/carbon support film and let dry for 4 h. The samples were then examined using
JEM1200EX II Transmission electron microscope (TEM) (JEOL Ltd, Tokyo, Japan). To
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further examine the size of the NPs, dynamic light scattering (DLS) was used to measure
the hydrodynamic size of the IO and IO-Au NPs on a Malvern Zetasizer Nano ZS90 at
room temperature (Brookhaven Instruments Corp, NY, USA).
2.4 Surface enhanced Raman scattering measurement
The IO-Au SERS NPs (nanospheres, nanoovals, nanopins) were prepared by
direct adsorption of QSY21, followed by stabilization with methoxy-poly (ethylene)
glycol (mPEG-SH). First, 50 µL, 0.1mM QSY21 was added to 1 mL of 0.1 nM IO-Au
NPs. The mixture was vortexed in the dark for 15 min to allow the adsorption of the dye
onto the NPs. This was followed by the addition of 50 µL, 0.1 mM mPEG-SH to saturate
and stabilize the surface of the NPs. The mixture was vortexed for 2 h in the dark at
room temperature. The resulting mPEG/QSY/IO-Au NPs were centrifuged and washed 3
times (10,000 rpm, 10 min) to separate unbound molecules. The NPs were redispersed in
1 mL ultrapure water. The molar ratios of QSY and mPEG-SH to IO-Au NPs were
5x104:1, which were calculated based on their volume and molar concentrations. The
molar concentration of the IO-Au NPs are calculated based off of the stock IO NP
concentration, 0.29 µM. The working IO-Ag+ seed solution concentration is 0.01 µM.
The concentration of IO-Au NPs can then be controlled by the amount of seed injected
into the 1.5 mL growth solution. For a 22 µL sample, the concentration of IO-Au NPs is
~0.1 nM. This concentration accounts for a 10 percent loss after many purification steps.
The SERS signals were collected from 0.1 nM IO-Au SERS NPs on a ProRaman-L
porter Raman spectrometer (Enwave Optronics, Irvine, CA). The focus of the laser was
adjusted to obtain maximum signal. The signals were detected with a CCD camera cool
to -60oC. The excitation wavelength was 785 nm and the power was 10 mW with an
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acquisition time of 0.1 s. A baseline correction using multi-segment polynomial fitting
(Provided by Enwave) was utilized to subtract the background.
2.5 Photothermal experiment
To examine the photothermal effect of the nanoparticles, 808 nm CW NIR light
from a portable diode laser (Power technologies, Little Rock, AR) was delivered to the
NP solution (100 µL) at the specified concentration in a 1.7 mL microcentrifuge tube.
The particles were irradiated for up to 8 minutes. The laser beam was 1 cm in diameter
and the power density was 0.55 W/cm2. A thermocouple was inserted into the solution
perpendicular to the laser path to measure the temperature of the solution.
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CHAPTER 3. RESULTS AND DISCUSSION
3.1 Synthesis and characterization of iron oxide-Ag Seed
We used SHP 25 IO NPs to make IO-Au NPs in different shapes. The NPs are
spherical and averagely 23 nm in diameter and are highly monodisperse. (from 100 NPs)
(Figure 3.1). The NPs do not show any strong absorption peaks above 400 nm. (Figure
3.2). The NPs consist of a monolayer of oleic acid and a monolayer of amphiphilic
polymer (poly(maleic anhydride-alt-1-octadecene) that interacts with oleic acid with their
hydrophobic alkyl chain while exposing the hydrophilic carboxylate ions to anchor
positively charged metal ions. The reactive carboxylate groups also make the NPs water
soluble and highly negatively charged, with zeta potential of – 30 to -50 mV.

(a)

(b)

3.1. (a) TEM image IO NPs. (b) size distribution of IO NPs.

The magnetic properties of the IO NPs were tested by placing them against an
external magnet (surface field: 5000 Gauss, Figure 3.3(a)). The solution of NPs appeared
brown before magnetic separation. After separation, the particles were attracted to the
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magnet and separated from the aqueous solution The particles are completely attracted to
the magnet within a few hours. The magnetic properties were also quantitatively
examined with a magnetometer at room temperature. Figure 3.3(b) shows the M-H curve
of the iron oxide particles. The NPs are superparamagnetic which is crucial for
biomedical applications to avoid magnetization residue-induced aggregation. The NPs
display a strong magnetization, with a saturation magnetization of ~50 emu/g.

Figure 3.2. Absorption spectra of IO NPs.
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Figure 3.3. (a) Magnetic separation of IO NPs in the presence of an external magnetic
field. (b) M-H curve of IO NPs at room temperature. The nanoparticles display a
superparamagnetic curve.
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The amphiphilic polymer layer with carboxyl groups on the surface allowed for
silver ammonia complex ions (Ag(NH3)2+) to adsorb onto the surface of the IO NPs.
Ag(NH3)2+ is known to be adsorbed onto negatively-charged NPs with high density by
electrostatic interactions.66 This enables facile formation of small Ag NPs (~2 nm) on the
surface of the IO NPs by reduction with sodium borohydride (Figure 3.4). The small Ag
NPs on the surface of the IO NPs were used as the catalyst for Au shell growth. Without
the Ag NPs on the IO NPs, IO-Au core-shell NPs were not formed, leading us to believe
the fine Ag NPs on the surface of the IO served as nucleation sites.

3.4. TEM image of IO NPs (~20 nm) with 2-3 nm Ag NPs attached to the surface used as
the catalyst for the formation of the Au shell onto the IO NPs.

3.2 Synthesis and characterization of IO-Au nanospheres
The geometry of IO-Au NPs was controlled by the concentration of AgNO3 and
AA in the growth solution. To make spherical IO-Au NPs, there was no AgNO3 in the
growth solution. The concentration of AA was 61 uM. The growth solutions (1.5 mL)
were kept at 25oC in a water bath. This was crucial due to the fact that the CTAB will
precipitate out of solution below 23oC leading to polydispersed nanoparticle formation.
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Within a minute of the IO-Ag seed particle being injected into the spherical growth
solution a pink color started to appear. The final color of the spherical NPs appeared to
be a pink to red color. This is similar to the color of solid Au nanospheres (NSs). The
surface catalyzed reduction of HAuCl2 led to the formation of uniform Au shells on the
IO NPs. After purification by centrifugation (10,000 rpm, 8 min, 23oC), the hybrid NPs
were stable at room temperature for months. By adding different amounts of seed NPs,
IO-Au nanospheres with different sizes were prepared. Figure 3.5 shows the absorption
spectra of various sizes of IO-Au NSs by adding different amounts of IO-Ag seeds from
2 to 26 uL (~0.1 nM). IO NPs do not absorb light in the VIS-NIR region (Figure 3.2).
However, IO-Au core-shell NSs exhibited strong surface Plasmon resonance (SPR)
absorption in this region (Figure 3.5). The more seed that was added, the smaller IO-Au
NSs were formed due to limited amount of gold solution. As the size of the NPs
increased, the SPR slightly red shifts. This is similar to Au NSs, which also exhibit a
similar red shift with an increase in size.67 Further increasing of the sizes lead to
spectrum broadening (Figure 3.5).
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Figure 3.5. The absorption spectra of IO-Au nanospheres with varying amount of IO-Ag
seed. As the particle size increases (decreased amount of seed), the surface Plasmon
resonance absorption slightly red shifts from 530-560 nm.

The size and morphology of the NPs were characterized via TEM (Figure 3.6). It can be
seen that uniform IO-Au NPs were formed. The IO-Au NSs appear darker than the IO
NPs (Figure 3.1(a)). This is expected as Au has a much higher density compared to Fe.
It is well known that elements with higher densities have better contrast in TEM.68 The
sizes of IO-Au NSs were tuned by varying the amount of IO-Ag seed. When 26 µL IOAg seed were injected, there were still free IO NPs in the solution (Figure 3.6(a))
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(a)

(b)

(c)

(d)

Figure 3.6. (a) TEM image of ~40-50 nm IO-Au nanospheres (26 µL seed). The Au shell
grows uniformly onto the IO-Ag seeded particle. (b) TEM image of ~50-60 nm IO-Au
nanospheres (22 µL seed). (c) TEM image of ~70-80 nm IO-Au nanospheres (14 µL
seed) and (d) TEM image of ~100-110 nm IO-Au nanospheres (2 µL seed)

The size of the IO-Au NPs (26 uL) was about 40 to 50 nm. As the IO core is
about 25 nm, the shell of Au is 7 – 13 nm. When the amount of seed NPs was reduced to
22 uL, free IO NPs were barely observed (Figure 3.6(b)). The size of the hybrid NPs
increased to 50 to 60 nm. When the amount of seed NPs was further reduced to 2 uL, the
size of the IO-Au NPs increased to above 100 nm, with the Au shell of over 35 nm in
thickness.
TEM can determine the size and examine the shape of the NPs. However, they
cannot obtain information on the surface charge. In addition, the surface capping
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materials (CTAB in our studies) might also contribute the size of the NPs. Thus, we
further examined the hydrodynamic diameter (HD) of the IO-Au NPs in aqueous
solution. Table 3.1 shows a summary of the HD and zeta potential () of IO-Au NPs
made from different amount of seed. By decreasing the amount of IO-Ag seed injected
into the growth solution, the IO-Au NPs size increases. The HD is slightly larger than the
size measured by TEM due to the CTAB bound to the IO-Au NPs and outer hydration
layer. The CTAB attached to the surface of the NPs caused the NPs to have a positive
surface charge as shown by the zeta potential  in Table 3.1.

Table 3.1. Hydrodynamic diameter (HD) and Zeta Potential () of IO-Au
nanospheres prepared from different amount of seed.
IO-Ag seed amount (µL)

Hydrodynamic Diameter
(nm)

Zeta Potential
(mV)

26

68.0  2.2

28.5  0.5

22

75.7 2.0

29.4  0.7

18

84.1  1.1

30.8  0.8

14

95.3  2.6

30.5  0.5

10

105.0  4.1

29.9  0.6

6

109.8  6.5

30.5  0.7

2

116.5  3.5

31.3  0.7

Next the magnetic properties of the IO-Au NSs were tested by placing the NP
solution against an external permanent magnet (surface field: 5000 Gauss). Figure 3.7
shows the pictures of the NP solution before and after separation of the NPs from 2 - 26
uL samples. The 26, 22, 18, and 14 uL IO-Au NPs were attracted to the magnet after 2 h,
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leaving a clear solution. This indicates the good magnetic properties of the NPs. This
further confirmed that the NPs are indeed core-shell NPs, not solid Au NPs. When the
size of the NPs increased, the magnetic properties decreased and the NPs could not be
completely separated from solution. In fact, for the 2 uL sample there was no magnetic
separation. This is because of the increased content of diamagnetic Au for larger NPs.

Figure 3.7. Magnetic separation of IO-Au NSs prepared from different amounts of seed
from 26 uL -2 uL (left to right). The top is an image of the NPs before exposure to the
magnet. The bottom image is taken after 2 hours. The 26-14 uL seed samples show
excellent magnetic separation with all of the NPs attracted to the magnet. In the 10 uL
sample most NPs are attracted to the magnet, but there are some NPs that sediment down
to the bottom of the tube. 6 and 2 uL samples are too large to be magnetically separated.

3.3 Synthesis and characterization of IO-Au nanoovals

Compared to spherical NPs, anisotropic NPs gave better or new properties due to
curvature effects.69 Thus, we tried to make anisotropic IO-Au NPs, which would have
promising biomedical applications. Fortunately, we found we could make anisotropic IO-

32

Au core-shell NPs using the same method to the preparation of IO-Au nanospheres with
modifications. In addition, we could make different shapes of IO-Au NPs by controlling
the synthetic parameters. Using these altered conditions we made IO-Au NPs in oval and
pin shapes.
The IO-Au nanoovals (NOVs) were made from the same procedure to that of the
IO-Au NSs described above except that the growth solution contained AgNO3. Ag+ has
been shown to make anisotropic NPs by selectively binding to the (111) facet of gold
surface.70 The effect of AgNO3 in the growth process of the IO-Au core-shell NPs was
first tested by varying the amounts of AgNO3 in the growth solution. Figure 3.8 shows
TEM images of IO-Au NPs at different concentrations of AgNO3. The seed amount in
this experiment is 22 uL. When the concentration of AgNO3 was 40 uM, the particles
start to become anisotropic (Figure 3.8(b)) compared the IO-Au nanospheres without the
presence of AgNO3. When the concentration of AgNO3 was increased to 80 uM, the
particles then became more anisotropic and NPs appeared in oval shapes (Figure 3.8(c)).
After tripling the concentration of AgNO3 (120 uM), the particles became polydisperse
including appearance of some spherical NPs. Thus, IO-Au NOVs were made at an
optimum concentration of AgNO3 of 40 uM.
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Figure 3.8. TEM images of IO-Au NPs with varying silver ion concentration in the
growth solution. (a) No silver ions, (b) 40 uM AgNO3, (c) 80 um AgNO3 and (d) 120 uM
AgNO3.

After we obtained the optimal concentration of AgNO3 for making IO-Au NOVs,
we made IO-Au NOVs of different sizes (or different Au shell thickness) by using
different amounts of seed. By lowering the amount of seed, IO-Au NPs with larger sizes
were formed. Figure 3.9 shows that IO-Au NOVs exhibit SPR from 565 to 620 nm
depending on the amount of injected seeds. As the amount of seed decreased, the SPR
wavelength red shifted. Compared to the IO-Au nanospheres, which had SPR of 530-550
nm (Figure 3.5), the SPR of NOVs was slighted red shifted. It was also noted that the
absorption spectrum became broader with a decrease in the amount of seed NPs. This is
especially obvious when only 2 uL seeds were injected.
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Figure 3.9. Absorption spectra of IO-Au NOVs with varying amount of IO-Ag seeds.
The particles showed a SPR from 565 - 620 nm depending on the amount of seeds

Figure 3.10 shows TEM images of IO-Au NOVs prepared from different amounts
of seeds. When 22 uL IO-Ag seeds were used, the resulting IO-Au NPs were oval in
shape, with an average size (100 particles) of 60 nm along the long axis and 50 nm in
short axis (Figure 3.10 (a)). The shell of Au was estimated to be 12 to 18 nm in thickness
considering an IO core of 25 nm. When the size of the NPs increased, the oval shape
remained. The thickness of the Au shell increased proportionally in the oval shape. At
very low amounts of IO-Ag seed (2 - 6 uL), the NPs ranged from 80 to 120 nm in overall
size. These results showed that the size of the NPs could be tuned by controlling the
amount of the IO-Ag seeds in the growth solution.
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Figure 3.10. (a) TEM image of the IO-Au NOVs (22 uL seed). The particles are ~60 nm
along the long axis and ~50 nm in short axis. (b) TEM image of IO-Au NOVs (18 uL
seed). The NPs are ~70 nm along the long axis and 60 nm along the short axis. (c) TEM
image of IO-Au NOVs (10 uL seed). The NPs are ~90 nm along the long axis and 80 nm
along the short axis. (d) TEM image of IO-Au NOVs (6 uL seed). The NPs are ~90 nm
along the long axis and 120 nm along the short axis.

Similar to IO-Au NSs, the HD and  of the IO-Au NOVs were examined using
DLS. Table 3.2 shows the average HD and  of the IO-Au NOVs at different IO-Ag seed
injections. When the amount of seed was decreased, the sizes of the IO-Au NOVs
increased.  was around 30 mV due to the binding of positively charged CTAB
surfactant.
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Table 3.2. Hydrodynamic diameter (HD) and Zeta potential () of IO-Au NOVs at
various amounts of the seeds. The surface of the NPs are positively charged due to the
CTAB surfactant.
IO-Ag seed amount (µL)

Hydrodynamic Diameter
(nm)

Zeta Potential
(mV)

26

72.3  1.3

29.5  0.6

22

78.4 1.8

29.4  0.8

18

86.4  0.8

28.8  0.8

14

94.5  0.6

29.5  0.5

10

98.7  3.1

30.0  0.9

6

103.8  2.7

30.7  0.5

2

114.5  3.2

30.5  0.4

The magnetic properties of the IO-Au NOVs were tested by both qualitatively via
magnetic separation and quantitatively via a vibration magnetometer. We selected the
NOVs of 50 to 60 nm (seed 22 uL) for the measurement. Similar to IO-Au nanospheres,
the NOVs at these sizes showed strong magnetic properties. After the NOV solution was
attached to the magnet, the NPs were separated from the solution and attached to the wall
of the vial on the side of the magnet (Figure 3.11(a)). It took around 2 h for a complete
separation. This confirmed that the IO-Au NOVs maintained the magnetic properties of
the IO core.
For magnetic-related biomedical applications, the NPs have to be
superparamagnetic to avoid magnetization residue-induced aggregation. It is known that
the magnetic property of IO NPs is size dependent. The critical size for the
superparamagnetic property of IO NPs is < 30 nm, with larger size bearing ferromagnetic
properties. The IO NPs we used were 25 nm in diameter. We expect that the IO-Au
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NOVs would be superparamagtic, too. To further confirm whether the hybrid NOVs were
superparamagnetic, the magnetic properties were quantitatively examined using a
vibration magnetometer at room temperature. Figure 3. 11(b) shows the plot of the
magnetization of the NPs versus the applied external field (M-H curve). Similar to the IO
NPs, the NPs are superparamagnetic. The NOVs were magnetized under external
magnetic field. When the magnetic field was removed, the magnetization went back to
zero. However, the saturation magnetization of the NOVs were about 6 times lower than
that of pure IO NPs. (Figure 3.11 (b)). This is not surprising because of the mass
contribution from the diamagnetic Au that has 4 times larger density than IO. The CTAB
surfactant also contributed to the mass of the materials during the measurements.
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Figure 3.11. (a) Magnetic separation of IO-Au NOVs (50-60 nm) under external
magnetic field. The nanoparticle solution appeared purple before separation. The
solution becomes clear after the NPs were attracted to the magnet indicating the IO-Au
NOVs preserve the magnetic property of the IO core. (b) M-H curve for IO-Au NOVs
(50-60 nm). The NPs maintained the superparamagnetic properties of the IO core. The
NOVs have a saturation magnetization of ~8 emu/g.
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To examine the effect of the magnetic properties of the NOVs by the particle size,
we invested the magnetic separation of IO-Au NOVs of different size. Figure 3.12
showed the magnetic separation of IO-Au NOVs made from different amount of seeds (2
– 26 uL). Simialr to the spheres, increasing the size of the NPs lead to decreased
magnetic properties of the hybrid NPs. This is not surprising due to the increased
concentration of dimagnetic gold for larger NPs. For the hybrid NPs made from 2 uL
solution, the hybrid NOVs could not be completely separated even after overnight
exposure.

Figure 3.12. Magnetic separation of IO-Au NOVs prepared from different amount of seed
from 26 uL -2 uL (left to right). The top is an image of the NPs before exposure to the
magnet. The bottom image is taken after 2 hours. The 26-14 uL seed samples show the
NPs attracted to the magnet indicating they are indeed core-shell NPs. In the 10 uL
sample most NPs are attracted to the magnet, but there are some NPs that sediment down
to the bottom of the tube. 6 and 2 uL samples are not magnetically separated and show
sedimentation due to the large size of the NPs.
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3.4 Synthesis and characterization of IO-Au nanopins
During the growth of the gold shell, HAuCl2 was reduced by AA to Au0 that were
deposited onto the IO surface to form IO-Au core-shell NPs. The speed of deposition of
the Au atoms would greatly affect the shape of the hybrid NPs. Thus, we first examined
the role of AA on the shape of the IO-Au core-shell NPs using 18 uL seeds. The presence
of 1.6 mM AA in the growth solution containing 80 uM AgNO3 led to IO-Au NPs with
longer tips (Figure 3.14 (a)). The concentration of the AA is about 3 times higher than
that used for making NOVs. By further increasing the concentration of AA to 4 mM,
more NPs with pin like shapes were found (Figure 3.14 (b)). Further increasing AA to 8
mM did not increase the population of pin-shaped NPs, but increased the population of
IO-Au NSs. Thus, AA at 4 mM was the optimal concentration to make IO-Au nanopins.
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Figure 3.13. TEM image of IO-Au NPs prepared with (a) 1.6 mM AA, (b) 4 mM AA and
(c) 8 mM AA. AA with concentration equal or higher than 4 mM led to the formation of
pin-shaped IO-Au NPs. (d) Absorption spectra of IO-Au NPs prepared with 1.6 mM, 4.0
mM and 8.0 mM AA. 18 uL seeds were used in these samples.

The absorption spectra of these NPs are shown in Figure 3.13 (d). It shows that
the IO-Au NPs have two peaks, one strong peak at 600 nm and the other one in the longer
wavelength (Figure 3.13(d)). The 600 nm absorbance is most likely due to the presence
of IO-Au NSs and NOVs. The peak at longer wavelength is due to the presence of
NPINs. With the increase of AA, the intensity of the second peak increased. At 1.6 mM
AA, there was small peak at 775 nm. Increasing the concentration of AA to 4. 0mM led
to a strong peak at 850 nm. When the concentration of AA was further increased to 8
mM, the wavelength of this peak was blue shifted to 790 nm with a decrease in intensity.
This is consistent with the results from TEM. AA stimulated the formation of pin-shaped
41

NPs. However, too much AA would lead to destruction of the pin tips and thus giving
more spherical NPs.
We then made IO-Au NPINs with different sizes using different amount of seeds.
The amount of seeds used was 26, 22, 18 and 10 uL. The concentration of AA was 4 mM
and that of AgNO3 was 80 uM. Figure 3.14 showed the absorption spectra of these NPs.
As the amount of seeds increased, the peak for the NPINs in the NIR region was red
shifted. When 26 uL seeds were used, the NPINs showed a SPR at 774 nm. When 10 uL
seeds were used, the NPINs showed a SPR at 863 nm. This red shift was due to the
increase of the size of the NPs, which was confirmed by TEM examination discussed
below.
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Figure 3.14. Absorption spectra of IO-Au NPINs prepared from different amount of
seeds. (A) 26 µL, (b) 22 µL, (c) 18 µL seed and (d) 10 µL seed.

Figure 3.15 shows the TEM images of IO-Au NPINs prepared from different
amount of seeds. When 26 µL IO-Ag seed was used, the NPINs are 40-50 nm from the
tip to base and 25-35 nm along the base. When 22 µL IO-Ag seed was used, the IO-Au
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NPINs were typically 50-60 nm from the tip to base and 35-45 nm along the base (Figure
3.16). When the amount of the seeds was decreased to 18 uL, NPINs are 60-70 nm from
the tip to base and 40-50 nm along the base. When the amount of the seeds was further
decreased to 10 uL, the NPINs are 90-100 nm from the tip to base and 50-60 nm along
the base. In addition, the NPINs started to become polydispered and nanostars started to
form.

(a)

(b)

(c)

(d)

Figure 3.15. TEM images of IO-Au NPINs prepared from (a) 26 uL seeds, (b) 22 uL
seed, (c) 18 uL seeds and (d) 10 uL seeds. In (a), the NPINs are 40-50 nm from the tip to
base and 25-35 nm along the base. In (b), the NPINs are 50-60 nm from the tip to base
and 35-45 nm along the base. In (c), the NPINs are 60-70 from the tip to base and 40-50
nm along the base, and in (d), the NPINs are 90-100 nm from the tip to base and 50-60
nm along the base.
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Figure 3.16. TEM image of a IO-Au NPIN from 22 µL IO-Ag seed sample. The IO-Au
NPINs is 50 nm from the tip to base and 38 nm along the base.

To further examine the size tuning by varying the amount of seeds, we
characterized the NPs with DLS. Table 3.3 shows the average HD and  of the IO-Au
NPINs. As the IO-Ag seed amount was decreased, the overall size of the NPs increased.
Again, like the IO-Au NSs and NOVs, the NPINs were positively charged due the
charged CTAB capping materials.

Table 3.3. Hydrodynamic diameter (HD) and Zeta potential () of IO-Au NPINs at
various amounts of seeds. The NPINs have a positive surface charge.
IO-Ag seed amount (µL)

Hydrodynamic Diameter
(nm)

Zeta Potential
(mV)

26

65.3  2.4

28.5  0.7

22

68.0  1.9

28.4  0.6

18

78.2  1.7

29.7  0.4

14

82.1  2.6

29.8  1.1

10

92.2  4.2

29.8  0.5

6

103.7  3.5

30.1  0.9

2

108.5  5.2

30.3  0.8
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From the above studies, we can see that it was difficult to make high quality IOAu NPINs. At all conditions, IO-Au NSs contamination exists. Thus, to obtain pure IOAu NPINs, the sample was further processed by centrifugation at a specific speed and
time so that significant amount of NSs were able to be separated. We conducted a
systematic study, in which the as-prepared IO-Au NPINs were processed at different
centrifugation time and speed. The as-prepared NP solution (1.5 mL) was centrifuged at a
specified speed and time. After centrifugation, the supernatant and the pellet were quickly
separated. Then, a thin blue film was found on the inner wall of the centrifugation vial.
The film was rinsed off by water and collected for absorption measurement. Figure 3.17
showed the absorption spectra of the sample collected from the inner wall of the
centrifugation vial after centrifuged at different conditions. It is very clear that
centrifugation led to the separation of IO-Au NSs and thus the increase of the population
of IO-Au NPINs (increased intensity of the absorption peak in the NIR region). Lower
speed favours the separation of NSs. As the speed was decreased, the centrifugation time
was correspondingly increased. The IO-Au NPINs obtained from the separation of asprepared solution at 2000 rpm, 45 min showed an dominate peak around 810 nm from
IO-Au NPINs.
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Figure 3.17. Absorption spectra of IO-Au NPINs (22 uL seed) after separation of IO-Au
nanospheres by centrifugation at different speed and different time. The as-prepared
solution showed a major peak at 570 nm from IO-Au NSs and a second peak at 770 nm
from IO-Au NPINs. When the solution was centrifuged at 5500 rpm for 20 min, the
percentage of NPINs increased leading to the increase of the SPR bands at 780 nm. When
the solution was centrifuged at 2000 rpm for 45 min, the intensity of the SPR band at the
longer wavelength is stronger than the NSs, due to the separation of majority of NSs.

We further estimated the extinction coefficient of the IO-Au NPINs based on the
injected amount of seeds and the relative ratio of IO-Au NPINs and NSs based on TEM.
We found that the extinction coefficient of the NPINs was 4.3 x 1010 M-1cm-1 at 800 nm.
This is about an order of magnitude higher than gold nanorods. Such a high absorption
efficiency may benefit many applications including photothermal therapy.
The magnetic properties of IO–Au NPINs were confirmed by their separation
under external magnetic field. We selected the NPINs made from 22 uL seeds for this
study. This is because the NPINs of this size (50-60 nm in the longitudinal axis and 35-45
nm in the transverse axis) had the SPR around 800 nm, a wavelength that overlapped
very well with the laser wavelength used in photothermal therapy ( = 808 nm). When an
external permanent magnet was placed close to the IO-Au NPIN solution, the NPs were
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attracted to the magnet, indicating the strong magnetic properties (Figure 3.18 (a)). The
remaining liquid became colorless, indicating that the NPs were indeed core-shell NPs
and preserved the magnetic properties of the IO core. The magnetic properties were
quantitatively examined using a vibration magnetometer at room temperature (Figure
3.18 (b)). The saturation magnetization of the NPINs was about 6 emu/g. Compared to
the pure IO NPs (Figure 3.3(b)), the gold coating reduced the magnetization about 8
times. Similar to the IO-Au NOVs, the reduced magnetization is due to the larger density
of the diamagnetic gold shell compared to the IO core. The mass of the CTAB also
slightly contributes to the loss of magnetization.
In summary, we made a new generation of compact, uniform and NIR-absorbing
magnetic-optical NPs. With the presence of 80 uM silver nitrate and 4 mM AA, IO-Au
NPINs were formed. The NPINs with absorption maxima around 800 nm has an average
size (100 particles) about 50 nm from the tip to the base and 35 nm along the base. Most
importantly, we found that the hybrid nanopins exhibit extraordinary optical properties
which are highly promising for a widespread of biological and medical applications.
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Figure 3.18. (a) Magnetic separation of IO-Au NPINs placed against an external magnet.
The nanoparticle solution appeared blue before separation. The solution became clear
after the NPs were attracted to the magnet indicating that the IO-Au NPINs preserved the
magnetic property of the IO core. (b) M-H curve for IO-Au NPINs. The NPs maintain the
superparamagnetic properties of the IO core. The NPINs have a saturation magnetization of ~ 6
emu/g.

3.5 Surface enhanced Raman scattering activities of iron oxide-gold nanoparticles
Surface enhanced Raman scattering (SERS) is one of the most powerful tools for
biophysical and biomedical detections. As the enhancement can be as large as 10 14-15, it
enables detection at single molecule/particle level.71 A key challenge in engineering IOAu NPs for SERS applications is to optimize size and geometry without dampening the
magnetic properties. This is because SERS signals increase as the shell thickness
increases.72 However, increasing the Au shell results in the decrease of the relative
contribution from the magnetic IO in the hybrid NPs because Au is diamagnetic.
Anisotropic NPs are known to give much stronger electronic field enhancement than
isotropic spheres, a phenomenon that directly leads to increased Raman enhancement.73
Here, we study the adsorption of a Raman tag, QSY 21, to the different IO-Au core-shell
NPs synthesized hoping to achieve strong SERS activity from the anisotropic core-shell
48

NPs. The Au shell on the IO NPs makes this a very facile process. We chose the same
overall particle size of 50-60 nm for the IO-Au spheres, ovals, and pins because at this
size the core-shell NPs still posses excellent magnetic separation as well as strong optical
properties. This size is also an optimum size for biomedical applications.
The SERS NPs were prepared by nonspecific adsorption of QSY 21, followed by
covalent stabilization with mPEG-SH 5000 (Figure 3.19 using NOVs as an example).
The mPEG-SH binding sites did not compete with the sites on the NPs for QSY 21. Thus,
QSY 21-adsorbed IO-Au NPs were stabilized by hydrophilic PEG. We chose QSY 21
(see Figure 3.20 for the structure) as the Raman tag because of its highly delocalized pi
electrons that usually lead to strong Raman signals74. In addition, they are nonfluorescent
and thus do not produce a background that could lead to interference of the Raman
signals.

Figure 3.19. Schematic illustration of the preparation of IO-Au SERS NOVs.

Figure 3.20. Structure of QSY 21.
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First, the maximum loading efficiency of QSY was determined by adding various
amounts of QSY to the IO-Au NPs. Ratios of IO-Au NPs to QSY tested were 1:10,000,
1:25,000, 1:50,000, 1:75,000, and 1:100,000. The ratios above 1:50,000 aggregated and
therefore were not characterized further. The 1:50,000 ratio of NP:QSY was studied
using DLS measurements. The size and zeta potential were taken after each step to
characterize successful loading of QSY onto IO-Au NPs (Table 3.4 using NOVs as an
example). After the addition of QSY the size increased by 1.2 nm and the zeta potential
decreased by ~4 mV. This is expected as the QSY molecules are slightly negatively
charged. After finding the optimal loading efficiency of NPs:QSY (1:50,000) without NP
aggregation, this ratio was used for nanospheres, nanovals, and nanopins for a
comparative study of their SERS properties. After the IO-Au NPs were mixed with QSY,
the NPs were then coated with mPEG-SH (1:50,000) for stabilization of the QSY
adsorption via the Au-S covalent bond. Table 3.4 shows that after the addition of mPEGSH the hydrodynamic size of the QSY-IO-NPs increased by ~ 15nm while the zeta
potential decreased by ~ 17 mV. This is expected as the size of the mPEG 5K is
approximately 15-20 nm. The decrease in zeta potential is due to the exchange of the
positively charged CTAB with the mPEG-SH. After reaction, the desired SERS NPs
were separated by centrifugation and were resuspended in PBS.
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Table 3.4. Hydrodynamic Diameter (HD) and zeta potential () at each step of the
synthesis of SERS tagged IO-Au NOVs.
Hydrodynamic size (nm) Zeta Potential
(mV)
IO-Au NOVs
72.0  2.2
28.5  0.5
QSY21/IO-Au NOVs
73.2  2.7
24.8  0.8
mPEG/QSY21/IO-Au NOVs
88.1  1.5
7.8  1.2

The SERS signals from all the NPs were collected at the same power and same
concentration of core-shell NPs using a portable Raman spectrometer (Enwave). The
concentration of the NPs was 0.1 nM., the power of the laser was 25mW and the
integration time was 1 s. The excitation laser wavelength was 785 nm. Figure 3.21 shows
the SERS of QSY reporters from the IO-Au NSs. The QSY gave a strong peak around
1496 cm-1, with the intensity around 1200 a.u. The pure QSY solution as high as 1 mM
did not show any Raman signal (data not shown). This indicates that IO-Au NSs
enhanced the Raman signals of QSY.
The SERS signals from IO-Au NOVs and NPINs are shown in Figure 3.22. The
peak intensity at 1496 cm-1 was 55,000 a.u. for NOVs and 40,000 a.u. for NPINs.
Compared to the signal intensity (1200 a.u.) for NSs in Figure 3.21, the NOVs gave a 45
times stronger SERS activity and the NPINs gave 33 times stronger SERS activity than
NSs. This indicates that the IO-Au NOVs and IO-Au NPINs are very promising for
SERS-based molecular diagnosis. The strong peaks at 1333, 1584 and 1641 cm-1 are from
the xanthene ring stretching vibrations of the molecules.69
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Figure 3.21. SERS spectra of QSY 21 adsorbed onto IO-Au nanospheres (50-60 nm). The
strongest peak at 1496 cm-1 is ~ 1200 counts. Excitation wavelength: 785 nm; power: 25
mW; NP concentration: 0.1 nM; acquisition time: 1 sec.
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Figure 3.22. SERS spectra of QSY 21 adsorbed on IO–Au NPINs (black), IO–Au NOVs
(red). Excitation wavelength: 785 nm; power: 25 mW; NP concentration: 0.1 nM;
acquisition time: 1 sec.
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3.6 Photothermal properties of iron oxide-gold nanoparticles
PTT based on NIR-absorbing NPs has become a sought-after treatment in
nanomedicine in the last decade. NIR absorption is critical for in vivo imaging and
therapy because of minimal light absorption by water and hemoglobin and the resulting
optimal tissue penetration of the light in this region Silica/gold nanoshells, gold nanorods
(Au NRs), gold nanocages and hollow gold nanospheres have been widely used for
photothermal cancer therapy.20 However, these nanoparticles do not possess high
resolution imaging modalities such as MRI which are essential for the identification of
cancer and thus better treatments. By incorporating a magnetic IO core inside the Au
NPs, dual MRI/PTT will be possible with the single nanoparticles. This led to the study
of the photothermal properties of the IO-Au NPINs, NOVs and spheres. For this study
all particles had the same overall size of 50-60 nm, the same as the SERS experiment
discussed above. These sizes were chosen because they displayed optimum SERS
signals while maintaining strong magnetic properties. We examined the potency of the
nanoparticles for photothermal therapy by irradiating the nanoparticle solutions (100 uL)
with a NIR laser. The NPs at specified concentration were exposed to the laser (= 808
nm, beam diameter: 1 cm, power density 0.55 W/cm2) with stirring and the temperature
of the solution was monitored using a hypodermic thermocouple for up to 8 minutes
(Figure 3.23). As is expected the IO-Au NSs (blue curve) did not cause heating with a
NIR laser. This is because the NSs absorb light from 530-560 nm and do not have any
absorption in the NIR window. The IO-Au NOVs cause heating with exposure to the
NIR laser which is expected because they have slight absorption in the NIR region. The
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NPINs show the highest capability of heating up to 59oC. This is due to the strong
absorption in the NIR region (800 nm).

Figure 3.23. Photothermal heating of IO-Au NPs upon exposure to a NIR laser. IO-Au
nanospheres (blue) show no significant heating. The IO-Au NOVs (red) show heating up
to ~44oC. The NIR absorbing NPINs (green) show heating up to ~59oC. Laser
wavelength: 808 nm. Laser intensity: 0.55 W/cm2.

The IO-Au NPINs were further studied due to their excellent photothermal
properties as shown in Figure 3.24. Au Nanorods are well known for their bimodal
absorption and strong absorption in the NIR region. Au NRs are one of major
photothermal contrast agents in cancer therapy.26 This led us to compare the
photothermal properties of Au NRs and our IO-Au NPINs. The temperature of a 0.01
nM IO-Au NPIN solution increased rapidly within the first 3 min, followed by gradual
elevation until reaching plateau around 59oC. As a comparison, the Au NR solution at
the same concentration raised the temperature of water only from room temperature,
23 oC, to 33oC. To raise the temperature to a comparable value of the IO-Au NPINs, the
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concentration of the rods has to be increased to 0.5 nM. Thus, the photothermal property
of core-shell NPINs is approximately 50 times better than that of Au NRs, due to the
much higher absorption coefficient of NPINs. Such an efficient laser heating profile
indicates the great potential of the new hybrid NPs for photothermal cancer therapy.
Further experiments on the concentration dependence showed that the temperature is
proportional to the concentration of the NPs (Figure 3.20). The NPINs of 0.005 nM and
0.02 nM gave a saturation temperature of 48 and 70oC, respectively.

Figure 3.24. Photothermal properties of IO–Au NPINs. (A) Comparison of the
photothermal effects of IO–Au NPINs and Au NRs; (B) concentration dependence of the
photothermal effects of IO–Au NPINs. IO–Au NPs give similar heating profiles to Au
NRs with 50 times higher molar concentrations. Laser wavelength: 808 nm; power
density: 0.55 W cm
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CHAPTER 4: CONCLUSIONS AND OUTLOOK
The work in this thesis focused on the synthesis of compact IO-Au core-shell NPs
with facile tuning of the size and shape of the NPs using a seed mediated growth method.
In addition to the synthesis of the NPs, the distinct properties from the IO core and IO-Au
hybrid NPs were characterized. The SERS activities and photothermal effects were
investigated for each type of IO-Au NPs including NSs, NOVs and NPINs.
The IO-Au NSs showed facile tuning of the overall size ranging from 40 to 120
nm. The results from the absorption spectra showed that the IO-Au NSs exhibited a
strong surface Plasmon resonance ascribed to the Au shell. Furthermore, the IO-Au NSs
show that they are responsive to an external magnetic field indicating the retention of the
magnetic properties of the IO core. The SERS data shows that the SERS tagged NSs had
a weak Raman intensity of ~ 1200 counts which is expected from the QSY21 Raman
reporter that were nonspecifically adsorbed onto the NPs. The NSs did not show any
photothermal heating when irradiated with a NIR laser, which is expected due to the lack
of NIR absorption of the NPs.
The synthesis of compact anisotropic IO-Au core-shell NPs still remains a major
challenge today. In this study we developed a simple method to synthesize anisotropic
NPs by modifying the procedure for the synthesis of IO-Au NSs. By simply adding
AgNO3 to the growth solution, compact IO-Au NPs in oval shapes were formed. The
TEM showed that the NPs had a faceted oval shape. The size of the NOVs was also
easily tuned from 40 to 120 nm. The size was precisely controlled by varying the amount
of IO seed particles injected into the growth solution. The results showed the IO-Au
NOVs had a much stronger SERS effect than the NSs. In fact, the NOVs had ~ 45 times
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stronger SERS signals versus the spheres of the same overall size. The IO-Au NOVs also
showed photothermal heating once irradiated with a NIR laser. After irradiation for 8
minutes, the NP solution reached a temperature of approximately 44oC. The NOVs were
separated from the solution by an external magnet, indicating their good magnetic
properties. Quantitative measurement showed that the NOVs are superparamagnetic,
similar to their IO cores. Overall the IO-Au NOVs display excellent optical properties as
well as magnetic properties.
In this thesis we have further made compact NIR absorbing IO–Au hybrid NPs in
pin shapes by adjusting the AA concentration in the growth solution. The size of the
NPINs was tuned from 40 to 100 nm. The NPINs display excellent photothermal
properties due to their surface Plasmon resonance band the NIR region. The results
indicate that the NPIN solution can reach up to 59oC upon irradiation. In fact, the
photothermal property of the NPINs is approximately 50 times stronger than that of Au
NRs which is due to the much higher absorption coefficient of NPINs. The results also
showed that the temperature is proportional to the concentration of the NPs. The NPINs
also exhibit excellent SERS properties as well. The NPINs have ~ 33 times stronger
signal of the same sized nanospheres. The NPINs also displayed magnetic separation
when placed against an external magnet. The compact NPINs also maintain the
superparamagnetic properties of the IO core.
In future studies, we aim to use these NPs for cancer diagnostics and treatment.
By using the facile surface chemistry of the Au shell one can conjugate tumor specific
ligands for specific targeting of cancer cells. These hybrid nanoparticles could allow for
the isolation, detection and therapy of cancer cells. For SERS-based cancer detection, the
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NOVs would be ideal due to their stronger SERS activities compared to the other two
shapes. The NPINs would be ideal for MR imaging and photothermal cancer therapy due
to their excellent NIR absorption properties.
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